The past decade has witnessed a substantial increase in the use of complementary and integrative modalities for the management of overall health and wellness. Integrative Medicine is grounded in the definition of health, and is an approach that strives to use the best evidence-based practices, rigorously developed and scientifically informed by medical research of safety and efficacy, to enhance optimal health outcome of conventional care. It puts the patient at the center and addresses the full range of physical, emotional, social, spiritual, and environmental influences that affect a person’s health and well-being (1). Integrative Medicine has gained recognition and establishment as a sub-specialty fellowship approved by the American Board of Integrative Medicine https://www.abpsus.org/integrative-medicine-fellowships/.
The Integrative Medicine course is complementary to the on-going training curriculum offered by the NCI Center for Cancer Training, including the flagship course, Translational Research in Clinical Oncology (TRACO). The Spring 2021 course will be virtual at http://cbiit.webex.com and there is no registration fee for this course. Registration for the “Psilocybin Research Speaker Series” can be found here.
This course is designed for NIH fellows who want to enhance and broaden their knowledge of evidence-based comprehensive integrative healthcare to improve the lives of patients, including those with cancer. Topics will be presented with research evidence, followed by clinical scenarios. Students will have opportunity to better understand the current state of the science of each subject, as well as be introduced to cutting-edge advances in medical research, including technological advances.
Location and Time
The Integrative Medicine course and ”Psilocybin Research Speaker Series” will occur from March 25-June 10, 2021. Certain time-sensitive and cutting edge lectures may be opened to the NIH staff as well as the public, to include those from academia and the private sector, creating a unique platform for scientific discourse. Speakers will represent experts (domestic and international) in the field from government, academia, and the community.
NIH ODS and Dietary Supplement
Nurtigenomics and personalized nutrition
Opioids and pain
B. Karp & D. Mohapatra
Psilocybin at the end of life
Neuropsychopharmacology of psilocybin
FDA cannabis clinical research guide
Annual IM and Women's Health webinar
T.Bao, J. Clayton, H. Langvin, J. Ligibel, W. Lu, W. McCaskill-Stevens, A. Magnuson, T. Sanft and IM staff
Science policy considerations and perspective
Psilocybin in cancer patients
Psilocybin and group therapy
Psychedelic medicine and ethics
B. Anderson & A. Danforth
P.S. Apperbaum & M. Marks
New insights into psilocybin
Antidepressant-like effects of psilocybin
Psilocybin assisted psychotherapy
Psilocybin Research Final QA and Discussion
TBD and NIH Staff
Faculty and Organizing Committee
- Ann Berger, M.D., Clinical Center, NIH
- Terry Moody, Ph.D., NCI, NIH
- David Shurtleff, Ph.D., NCCIH, NIH
- Dan Xi, Ph.D., NCI, NIH
- Farah Zia, M.D., NCI, NIH
- Integrative Medicine and the Health of the Public: A Summary of the February 2009 Summit. Washington (DC): National Academies Press (US); 2009. https://www.ncbi.nlm.nih.gov/books/NBK219629/
- Xi D, Bao T, Chen Q, et al. State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research-NCI Strategic Workshop Highlights of Discussion Report. J Natl Cancer Inst Monogr. 2017 Nov;2017(52):003. PMCID: PMC6061228
Related Training Opportunities
This course is part of an ongoing training curriculum for NCI clinical and postdoctoral fellows. Each fall CCT offers the Translational Research in Clinical Oncology (TRACO) course, hosted by Dr. Terry Moody.
NIH offers additional training opportunities.